RU2006133539A - Оксидекагидронафталиновые модуляторы нм74 - Google Patents

Оксидекагидронафталиновые модуляторы нм74 Download PDF

Info

Publication number
RU2006133539A
RU2006133539A RU2006133539/04A RU2006133539A RU2006133539A RU 2006133539 A RU2006133539 A RU 2006133539A RU 2006133539/04 A RU2006133539/04 A RU 2006133539/04A RU 2006133539 A RU2006133539 A RU 2006133539A RU 2006133539 A RU2006133539 A RU 2006133539A
Authority
RU
Russia
Prior art keywords
contain
combination
substituted
heteroatom
branched
Prior art date
Application number
RU2006133539/04A
Other languages
English (en)
Russian (ru)
Inventor
Анне МИННИХ (US)
Анне МИННИХ
Тереза КУНТЦВАЙЛЕР (US)
Тереза КУНТЦВАЙЛЕР
Хайфенг АЙСХИНГДРЕЛО (US)
Хайфенг АЙСХИНГДРЕЛО
Майкл АНГЕЛАСТРО (US)
Майкл АНГЕЛАСТРО
Стефан ХЕНКЕ (US)
Стефан ХЕНКЕ
Original Assignee
Авентис Фармасьютикалз Инк. (Us)
Авентис Фармасьютикалз Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Авентис Фармасьютикалз Инк. (Us), Авентис Фармасьютикалз Инк. filed Critical Авентис Фармасьютикалз Инк. (Us)
Publication of RU2006133539A publication Critical patent/RU2006133539A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
RU2006133539/04A 2004-02-20 2005-02-10 Оксидекагидронафталиновые модуляторы нм74 RU2006133539A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54601204P 2004-02-20 2004-02-20
US60/546,012 2004-02-20
PCT/US2005/004095 WO2005082352A1 (en) 2004-02-20 2005-02-10 Oxydecahydronaphthalene modulators of hm74

Publications (1)

Publication Number Publication Date
RU2006133539A true RU2006133539A (ru) 2008-03-27

Family

ID=34910747

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2006133539/04A RU2006133539A (ru) 2004-02-20 2005-02-10 Оксидекагидронафталиновые модуляторы нм74

Country Status (21)

Country Link
US (2) US7264937B2 (https=)
EP (1) EP1718293A1 (https=)
JP (1) JP2007526917A (https=)
KR (1) KR101145693B1 (https=)
CN (1) CN1929833A (https=)
AR (1) AR047708A1 (https=)
AU (1) AU2005216878B2 (https=)
BR (1) BRPI0507916A (https=)
CA (1) CA2556757C (https=)
CR (1) CR8537A (https=)
EC (1) ECSP066776A (https=)
IL (1) IL177106A (https=)
MA (1) MA28368A1 (https=)
ME (2) MEP17008A (https=)
NO (1) NO20064214L (https=)
RS (1) RS20060472A (https=)
RU (1) RU2006133539A (https=)
TN (1) TNSN06235A1 (https=)
TW (1) TWI354552B (https=)
WO (1) WO2005082352A1 (https=)
ZA (1) ZA200606687B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004083388A2 (en) * 2003-03-14 2004-09-30 Bristol-Myers Squibb Company Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74
CN101115726A (zh) 2004-12-03 2008-01-30 先灵公司 作为cb1拮抗剂的取代哌嗪
AR059021A1 (es) * 2006-01-18 2008-03-05 Schering Corp Moduladores de receptores cannabinoides
US20100197564A1 (en) * 2007-04-19 2010-08-05 Schering Corporation Diaryl morpholines as cb1 modulators
US8623873B2 (en) * 2007-06-28 2014-01-07 Intervet Inc. Substituted piperazines as CB1 antagonists
US20100286160A1 (en) * 2007-06-28 2010-11-11 Intervet Inc. Substituted piperazines as cb1 antagonists

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US5674908A (en) * 1993-12-20 1997-10-07 Life Technologies, Inc. Highly packed polycationic ammonium, sulfonium and phosphonium lipids
DE19624154A1 (de) * 1996-06-18 1998-01-08 Hoechst Ag Ringannelierte Dihydropyrane, Verfahren zur Herstellung sowie deren Verwendung
US6555339B1 (en) 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors
EP1007563A4 (en) * 1997-06-12 2003-04-16 Smithkline Beecham Corp HM74A RECEPTOR
GB0021484D0 (en) * 2000-09-01 2000-10-18 Boehringer Ingelheim Pharma Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases

Also Published As

Publication number Publication date
RS20060472A (sr) 2008-11-28
MEP17008A (hr) 2010-06-10
IL177106A (en) 2012-03-29
AR047708A1 (es) 2006-02-08
AU2005216878A1 (en) 2005-09-09
CR8537A (es) 2007-03-05
CN1929833A (zh) 2007-03-14
CA2556757C (en) 2011-05-03
TWI354552B (en) 2011-12-21
NO20064214L (no) 2006-09-18
ECSP066776A (es) 2006-11-16
US20080045586A1 (en) 2008-02-21
WO2005082352A1 (en) 2005-09-09
US7264937B2 (en) 2007-09-04
CA2556757A1 (en) 2005-09-09
ME00059B (me) 2010-06-10
JP2007526917A (ja) 2007-09-20
EP1718293A1 (en) 2006-11-08
IL177106A0 (en) 2006-12-10
TW200539864A (en) 2005-12-16
ZA200606687B (en) 2008-02-27
US20050187263A1 (en) 2005-08-25
KR20060127982A (ko) 2006-12-13
AU2005216878B2 (en) 2010-06-17
KR101145693B1 (ko) 2012-05-25
BRPI0507916A (pt) 2007-07-10
TNSN06235A1 (en) 2007-12-03
MA28368A1 (fr) 2006-12-01

Similar Documents

Publication Publication Date Title
RU2374241C2 (ru) N-ацилированные азотсодержащие гетероциклические соединения в качестве лигандов ppar-рецепторов, активируемых пролифератором пероксисомы
RU2011106374A (ru) Циклические ингибиторы 11бета-гидроксистероид-дегидрогеназы 1
RU2008112683A (ru) Ингибиторы fap
AR086367A1 (es) Compuestos de pirrolidinil urea y pirrolidinil tiourea como inhibidores de cinasa trka
RU2015133450A (ru) Соединения имидазопиридина и их применение
AR035773A1 (es) Compuestos diamino ciclico, composicion farmaceutica y su uso en la fabricacion de un medicamento util para modular la actividad de una quimioquina
JP2010529147A5 (https=)
AR043694A1 (es) Derivados ciclicos como moduladores de la actividad del receptor de quimiocina
HRP20120440T1 (hr) Inhibitori virusa hepatitisa c
EA200401613A1 (ru) Лекарственное средство для лечения рака
RU2394031C2 (ru) Соли четвертичного аммония в качестве антагонистов м3
RU2013119129A (ru) Органические соединения
MA38534A1 (fr) Compositions synergiques comprenant le (2s)-2-ethoxy-3-(4-(2-(2-methyl-5-(4-methylsulfanylphenyl)pyrrol-1-yl)ethoxy)phenyl)propanoate et des agents, par ex. Inhibiteurs de dipeptidyl peptidase-4, biguanide et/ou statines pour une utilisation dans la dyslipidémie
CO4950553A1 (es) Compuestos de 7-tetrahidroisoquinolinas y procedimiento para su preparacion
RU2006133539A (ru) Оксидекагидронафталиновые модуляторы нм74
ZA200800180B (en) Agent for the prevention and treatment of liver diseases containing pyrazolopyrimidinone derivative
RU2016104844A (ru) Производные n-мочевино замещенных аминокислот как модуляторы формил-пептидного рецептора
RU2009102270A (ru) Производные тиазолилмочевины в качестве ингибиторов фосфатидилинозитол-3-киназы
EA200800303A1 (ru) Применение производных и аналогов тиазола при нарушениях, вызванных свободными жирными кислотами
EA200700901A1 (ru) Производные 2-амидо-4-фенилтиазола, их получение и применение в терапии
RU2006133540A (ru) Фуросемидные модуляторы нм74
RU2008106754A (ru) Предотвращающий преждевременную овуляцию агент
RU2008107871A (ru) Применение ингибиторов hdac для лечения миеломы
RU2008130043A (ru) Комбинация, включающая комбретастатин и противораковые средства
EA200500691A1 (ru) ПРИМЕНЕНИЕ АГОНИСТА ПЕРОКСИСОМА ПРОЛИФЕРАТОР-АКТИВИРОВАННОГО РЕЦЕПТОРА АЛЬФА (PPARα) И МЕТФОРМИНА ДЛЯ СНИЖЕНИЯ УРОВНЯ ТРИГЛИЦЕРИДОВ В СЫВОРОТКЕ КРОВИ

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20090724